| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-06 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.25 | 0.0001 |